Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Sulphonamides
Revenue, means the sales value of Sulphonamides
This report studies sales (consumption) of Sulphonamides in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sulphonamides in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Split by applications, this report focuses on sales, market share and growth rate of Sulphonamides in each application, can be divided into
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Global Sulphonamides Sales Market Report 2017
1 Sulphonamides Overview
1.1 Product Overview and Scope of Sulphonamides
1.2 Classification of Sulphonamides
1.2.1 Orally Absorbable Sulfonamide
1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.3 Application of Sulphonamides
1.3.1 Skin Infections
1.3.2 Gastro Intestinal Tract (GIT) Infection
1.3.3 Meningitis
1.4 Sulphonamides Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Sulphonamides (2012-2022)
1.5.1 Global Sulphonamides Sales and Growth Rate (2012-2022)
1.5.2 Global Sulphonamides Revenue and Growth Rate (2012-2022)
2 Global Sulphonamides Competition by Manufacturers, Type and Application
2.1 Global Sulphonamides Market Competition by Manufacturers
2.1.1 Global Sulphonamides Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Sulphonamides Revenue and Share by Manufacturers (2012-2017)
2.2 Global Sulphonamides (Volume and Value) by Type
2.2.1 Global Sulphonamides Sales and Market Share by Type (2012-2017)
2.2.2 Global Sulphonamides Revenue and Market Share by Type (2012-2017)
2.3 Global Sulphonamides (Volume and Value) by Regions
2.3.1 Global Sulphonamides Sales and Market Share by Regions (2012-2017)
2.3.2 Global Sulphonamides Revenue and Market Share by Regions (2012-2017)
2.4 Global Sulphonamides (Volume) by Application
3 United States Sulphonamides (Volume, Value and Sales Price)
3.1 United States Sulphonamides Sales and Value (2012-2017)
3.1.1 United States Sulphonamides Sales and Growth Rate (2012-2017)
3.1.2 United States Sulphonamides Revenue and Growth Rate (2012-2017)
3.1.3 United States Sulphonamides Sales Price Trend (2012-2017)
3.2 United States Sulphonamides Sales and Market Share by Manufacturers
3.3 United States Sulphonamides Sales and Market Share by Type
3.4 United States Sulphonamides Sales and Market Share by Application
4 China Sulphonamides (Volume, Value and Sales Price)
4.1 China Sulphonamides Sales and Value (2012-2017)
4.1.1 China Sulphonamides Sales and Growth Rate (2012-2017)
4.1.2 China Sulphonamides Revenue and Growth Rate (2012-2017)
4.1.3 China Sulphonamides Sales Price Trend (2012-2017)
4.2 China Sulphonamides Sales and Market Share by Manufacturers
4.3 China Sulphonamides Sales and Market Share by Type
4.4 China Sulphonamides Sales and Market Share by Application
5 Europe Sulphonamides (Volume, Value and Sales Price)
5.1 Europe Sulphonamides Sales and Value (2012-2017)
5.1.1 Europe Sulphonamides Sales and Growth Rate (2012-2017)
5.1.2 Europe Sulphonamides Revenue and Growth Rate (2012-2017)
5.1.3 Europe Sulphonamides Sales Price Trend (2012-2017)
5.2 Europe Sulphonamides Sales and Market Share by Manufacturers
5.3 Europe Sulphonamides Sales and Market Share by Type
5.4 Europe Sulphonamides Sales and Market Share by Application
6 Japan Sulphonamides (Volume, Value and Sales Price)
6.1 Japan Sulphonamides Sales and Value (2012-2017)
6.1.1 Japan Sulphonamides Sales and Growth Rate (2012-2017)
6.1.2 Japan Sulphonamides Revenue and Growth Rate (2012-2017)
6.1.3 Japan Sulphonamides Sales Price Trend (2012-2017)
6.2 Japan Sulphonamides Sales and Market Share by Manufacturers
6.3 Japan Sulphonamides Sales and Market Share by Type
6.4 Japan Sulphonamides Sales and Market Share by Application
7 Southeast Asia Sulphonamides (Volume, Value and Sales Price)
7.1 Southeast Asia Sulphonamides Sales and Value (2012-2017)
7.1.1 Southeast Asia Sulphonamides Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Sulphonamides Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Sulphonamides Sales Price Trend (2012-2017)
7.2 Southeast Asia Sulphonamides Sales and Market Share by Manufacturers
7.3 Southeast Asia Sulphonamides Sales and Market Share by Type
7.4 Southeast Asia Sulphonamides Sales and Market Share by Application
8 India Sulphonamides (Volume, Value and Sales Price)
8.1 India Sulphonamides Sales and Value (2012-2017)
8.1.1 India Sulphonamides Sales and Growth Rate (2012-2017)
8.1.2 India Sulphonamides Revenue and Growth Rate (2012-2017)
8.1.3 India Sulphonamides Sales Price Trend (2012-2017)
8.2 India Sulphonamides Sales and Market Share by Manufacturers
8.3 India Sulphonamides Sales and Market Share by Type
8.4 India Sulphonamides Sales and Market Share by Application
9 Global Sulphonamides Manufacturers Analysis
9.1 Abbott Laboratories
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Sulphonamides Product Type, Application and Specification
9.1.2.1 Orally Absorbable Sulfonamide
9.1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.1.3 Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim Pharmaceuticals
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Sulphonamides Product Type, Application and Specification
9.2.2.1 Orally Absorbable Sulfonamide
9.2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Bayer AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Sulphonamides Product Type, Application and Specification
9.3.2.1 Orally Absorbable Sulfonamide
9.3.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.3.3 Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sulphonamides Product Type, Application and Specification
9.4.2.1 Orally Absorbable Sulfonamide
9.4.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 King Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Sulphonamides Product Type, Application and Specification
9.5.2.1 Orally Absorbable Sulfonamide
9.5.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Mylan Pharmaceuticals
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Sulphonamides Product Type, Application and Specification
9.6.2.1 Orally Absorbable Sulfonamide
9.6.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novartis International AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Sulphonamides Product Type, Application and Specification
9.7.2.1 Orally Absorbable Sulfonamide
9.7.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.7.3 Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Sulphonamides Product Type, Application and Specification
9.8.2.1 Orally Absorbable Sulfonamide
9.8.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.8.3 Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Par Pharmaceutical
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Sulphonamides Product Type, Application and Specification
9.9.2.1 Orally Absorbable Sulfonamide
9.9.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Roche Holding AG
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Sulphonamides Product Type, Application and Specification
9.10.2.1 Orally Absorbable Sulfonamide
9.10.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
9.10.3 Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Sanofi Aventis
9.12 Stiefel Laboratories
10 Sulphonamides Maufacturing Cost Analysis
10.1 Sulphonamides Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Sulphonamides
10.3 Manufacturing Process Analysis of Sulphonamides
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Sulphonamides Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Sulphonamides Market Forecast (2017-2022)
14.1 Global Sulphonamides Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Sulphonamides Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Sulphonamides Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Sulphonamides Price and Trend Forecast (2017-2022)
14.2 Global Sulphonamides Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Sulphonamides Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Sulphonamides Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Sulphonamides Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Sulphonamides
Table Classification of Sulphonamides
Figure Global Sales Market Share of Sulphonamides by Type in 2015
Figure Orally Absorbable Sulfonamide Picture
Figure Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Picture
Figure Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Picture
Table Applications of Sulphonamides
Figure Global Sales Market Share of Sulphonamides by Application in 2015
Figure Skin Infections Examples
Figure Gastro Intestinal Tract (GIT) Infection Examples
Figure Meningitis Examples
Figure United States Sulphonamides Revenue and Growth Rate (2012-2022)
Figure China Sulphonamides Revenue and Growth Rate (2012-2022)
Figure Europe Sulphonamides Revenue and Growth Rate (2012-2022)
Figure Japan Sulphonamides Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Sulphonamides Revenue and Growth Rate (2012-2022)
Figure India Sulphonamides Revenue and Growth Rate (2012-2022)
Figure Global Sulphonamides Sales and Growth Rate (2012-2022)
Figure Global Sulphonamides Revenue and Growth Rate (2012-2022)
Table Global Sulphonamides Sales of Key Manufacturers (2012-2017)
Table Global Sulphonamides Sales Share by Manufacturers (2012-2017)
Figure 2015 Sulphonamides Sales Share by Manufacturers
Figure 2016 Sulphonamides Sales Share by Manufacturers
Table Global Sulphonamides Revenue by Manufacturers (2012-2017)
Table Global Sulphonamides Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Sulphonamides Revenue Share by Manufacturers
Table 2016 Global Sulphonamides Revenue Share by Manufacturers
Table Global Sulphonamides Sales and Market Share by Type (2012-2017)
Table Global Sulphonamides Sales Share by Type (2012-2017)
Figure Sales Market Share of Sulphonamides by Type (2012-2017)
Figure Global Sulphonamides Sales Growth Rate by Type (2012-2017)
Table Global Sulphonamides Revenue and Market Share by Type (2012-2017)
Table Global Sulphonamides Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sulphonamides by Type (2012-2017)
Figure Global Sulphonamides Revenue Growth Rate by Type (2012-2017)
Table Global Sulphonamides Sales and Market Share by Regions (2012-2017)
Table Global Sulphonamides Sales Share by Regions (2012-2017)
Figure Sales Market Share of Sulphonamides by Regions (2012-2017)
Figure Global Sulphonamides Sales Growth Rate by Regions (2012-2017)
Table Global Sulphonamides Revenue and Market Share by Regions (2012-2017)
Table Global Sulphonamides Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Sulphonamides by Regions (2012-2017)
Figure Global Sulphonamides Revenue Growth Rate by Regions (2012-2017)
Table Global Sulphonamides Sales and Market Share by Application (2012-2017)
Table Global Sulphonamides Sales Share by Application (2012-2017)
Figure Sales Market Share of Sulphonamides by Application (2012-2017)
Figure Global Sulphonamides Sales Growth Rate by Application (2012-2017)
Figure United States Sulphonamides Sales and Growth Rate (2012-2017)
Figure United States Sulphonamides Revenue and Growth Rate (2012-2017)
Figure United States Sulphonamides Sales Price Trend (2012-2017)
Table United States Sulphonamides Sales by Manufacturers (2012-2017)
Table United States Sulphonamides Market Share by Manufacturers (2012-2017)
Table United States Sulphonamides Sales by Type (2012-2017)
Table United States Sulphonamides Market Share by Type (2012-2017)
Table United States Sulphonamides Sales by Application (2012-2017)
Table United States Sulphonamides Market Share by Application (2012-2017)
Figure China Sulphonamides Sales and Growth Rate (2012-2017)
Figure China Sulphonamides Revenue and Growth Rate (2012-2017)
Figure China Sulphonamides Sales Price Trend (2012-2017)
Table China Sulphonamides Sales by Manufacturers (2012-2017)
Table China Sulphonamides Market Share by Manufacturers (2012-2017)
Table China Sulphonamides Sales by Type (2012-2017)
Table China Sulphonamides Market Share by Type (2012-2017)
Table China Sulphonamides Sales by Application (2012-2017)
Table China Sulphonamides Market Share by Application (2012-2017)
Figure Europe Sulphonamides Sales and Growth Rate (2012-2017)
Figure Europe Sulphonamides Revenue and Growth Rate (2012-2017)
Figure Europe Sulphonamides Sales Price Trend (2012-2017)
Table Europe Sulphonamides Sales by Manufacturers (2012-2017)
Table Europe Sulphonamides Market Share by Manufacturers (2012-2017)
Table Europe Sulphonamides Sales by Type (2012-2017)
Table Europe Sulphonamides Market Share by Type (2012-2017)
Table Europe Sulphonamides Sales by Application (2012-2017)
Table Europe Sulphonamides Market Share by Application (2012-2017)
Figure Japan Sulphonamides Sales and Growth Rate (2012-2017)
Figure Japan Sulphonamides Revenue and Growth Rate (2012-2017)
Figure Japan Sulphonamides Sales Price Trend (2012-2017)
Table Japan Sulphonamides Sales by Manufacturers (2012-2017)
Table Japan Sulphonamides Market Share by Manufacturers (2012-2017)
Table Japan Sulphonamides Sales by Type (2012-2017)
Table Japan Sulphonamides Market Share by Type (2012-2017)
Table Japan Sulphonamides Sales by Application (2012-2017)
Table Japan Sulphonamides Market Share by Application (2012-2017)
Figure Southeast Asia Sulphonamides Sales and Growth Rate (2012-2017)
Figure Southeast Asia Sulphonamides Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Sulphonamides Sales Price Trend (2012-2017)
Table Southeast Asia Sulphonamides Sales by Manufacturers (2012-2017)
Table Southeast Asia Sulphonamides Market Share by Manufacturers (2012-2017)
Table Southeast Asia Sulphonamides Sales by Type (2012-2017)
Table Southeast Asia Sulphonamides Market Share by Type (2012-2017)
Table Southeast Asia Sulphonamides Sales by Application (2012-2017)
Table Southeast Asia Sulphonamides Market Share by Application (2012-2017)
Figure India Sulphonamides Sales and Growth Rate (2012-2017)
Figure India Sulphonamides Revenue and Growth Rate (2012-2017)
Figure India Sulphonamides Sales Price Trend (2012-2017)
Table India Sulphonamides Sales by Manufacturers (2012-2017)
Table India Sulphonamides Market Share by Manufacturers (2012-2017)
Table India Sulphonamides Sales by Type (2012-2017)
Table India Sulphonamides Market Share by Type (2012-2017)
Table India Sulphonamides Sales by Application (2012-2017)
Table India Sulphonamides Market Share by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Sulphonamides Global Market Share (2012-2017)
Table Boehringer Ingelheim Pharmaceuticals Basic Information List
Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Pharmaceuticals Sulphonamides Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Sulphonamides Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Sulphonamides Global Market Share (2012-2017)
Table King Pharmaceuticals Basic Information List
Table King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure King Pharmaceuticals Sulphonamides Global Market Share (2012-2017)
Table Mylan Pharmaceuticals Basic Information List
Table Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Pharmaceuticals Sulphonamides Global Market Share (2012-2017)
Table Novartis International AG Basic Information List
Table Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis International AG Sulphonamides Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Sulphonamides Global Market Share (2012-2017)
Table Par Pharmaceutical Basic Information List
Table Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Par Pharmaceutical Sulphonamides Global Market Share (2012-2017)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Holding AG Sulphonamides Global Market Share (2012-2017)
Table Sanofi Aventis Basic Information List
Table Stiefel Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sulphonamides
Figure Manufacturing Process Analysis of Sulphonamides
Figure Sulphonamides Industrial Chain Analysis
Table Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
Table Major Buyers of Sulphonamides
Table Distributors/Traders List
Figure Global Sulphonamides Sales and Growth Rate Forecast (2017-2022)
Figure Global Sulphonamides Revenue and Growth Rate Forecast (2017-2022)
Table Global Sulphonamides Sales Forecast by Regions (2017-2022)
Table Global Sulphonamides Sales Forecast by Type (2017-2022)
Table Global Sulphonamides Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...